xml:space="preserve">
xml:space="preserve">
Advertisement
Advertisement

Baltimore-based Camden Partners spins off Nexus biomedical technology group as Catalio Capital Management

A division of Baltimore-based private equity firm Camden Partners Holdings has spun off and rebranded to continue investing in biomedical technology firms.

Camden’s Nexus division, which has invested in companies out of Johns Hopkins and elsewhere, will become Catalio Capital Management, the new independent management company said Wednesday. It is wholly owned by managing partners George Petrocheilos and R. Jacob Vogelstein.

Advertisement

Camden and CEO and founder David Warnock helped create Nexus in 2016 by providing operating capital to launch its first fund.

“Our move to independence represents the natural evolution of our business, which has built a track record of investing in a variety of breakthrough biomedical technology companies around the globe,” Petrocheilos said in an announcement Wednesday.

Advertisement

Warnock also co-founded charter school Green Street Academy and was a mayoral candidate in the 2016 Democratic primary.

Catalio will focus on investing in a portfolio of biomedical technology companies founded by world-renowned scientist-entrepreneurs who are developing the next generation of drugs, devices and diagnostics. Partners include 25 scientists who also have started several companies based on their research.

Camden will not have any role in Catalio’s governance, though some Camden employees and partners will continue to be supportive limited partners. Key members of the Camden team formerly dedicated to Nexus will also join Catalio.

On Wednesday, Camden also announced that it has held a final close on its sixth private equity fund. Strategic Partners Fund VI, the latest fund in Camden’s Strategic Partners fund series, wrapped up fundraising efforts this month. It has $100 million in commitments from limited partners that include pension funds, endowments and foundations and other private equity funds.

Warnock founded Camden in 1995 after leaving T. Rowe Price and built it into one of the city’s oldest private equity firms. Camden has invested in more than 80 private businesses since its inception.

Recommended on Baltimore Sun

Advertisement
Advertisement